Financials
Financial year 2025
Revenue
€ 164.7 million
▲ 9% vs 2024
Profit
Healthy€ 43 million
Debts
Low€ 56.3 million
▼ 93% vs 2024
Boehringer Ingelheim SComm from Elsene, company number BE0435953632, closed financial year 2025 with a result of € 43 million after tax. For that financial year Boehringer Ingelheim SComm recorded revenue of € 164.7 million and equity of € 1,537.7 million. Compared with financial year 2024, the result moved from € 43.1 million to € 43 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
What happened at Boehringer Ingelheim SComm?
What happened at Boehringer Ingelheim SComm in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lukas Hauschild stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 43 million. Source: NBB ↗
- Christoph Tautphäus stepped down as director. NBB
- Lukas Hauschild became a director. NBB
- Sebastian Guijarro stepped down as director. NBB
- Christoph Tautphäus became a director. NBB
- Sebastian Guijarro became a director. NBB
- New establishment in Brussel. KBO
In short
From € 7.4 million profit in 2021 to € 43 million profit in 2025.
Paid € 19.6 million in corporate taxes since 2021.
Best year ever: 2024, with € 43.1 million profit.
Paid out € 115.9 million in dividends to the owners in total.
A new publication or filing at Boehringer Ingelheim SComm? We notify you, reason included.
Follow Boehringer Ingelheim SCommNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Boehringer Ingelheim Centre SA, C.H. Boehringer Sohn and Boehringer Ingelheim Europe GmbH.
Directors
According to the 2025 annual accounts
Sebastian Guijarro
Manager
Also active at: Boehringer Ingelheim Animal Health Belgium SA, BOEHRINGER INGELHEIM CENTRE SA
since 2024 · until 2025
Christoph Tautphäus
Manager
Also active at: BOEHRINGER INGELHEIM CENTRE SA, Boehringer Ingelheim Veterinary Medicine Belgium NV
since 2025 · until 2026
Lukas Hauschild
Manager
Also active at: Boehringer Ingelheim Animal Health Belgium SA, BOEHRINGER INGELHEIM CENTRE SA
since 2026 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Arnaud Fraiteurlaan 15/23
1050 Elsene
Maria van Bourgondiëstraat 58
1000 Brussel
Active since 1 January 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
Laboratoires Titra
€ -7,222 gross margin · 2024
Boehringer Ingelheim Animal Health Belgium SA same network
€ 50.6 million revenue · 2025
BOEHRINGER INGELHEIM CENTRE SA same network
A.J.B. INTERIEUR
€ 26,086 gross margin · 2025
Krys Construct
€ 25,462 gross margin · 2024
+26 more
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
Website info
Features
Security
Network
Details
- Company number
- 0435.953.632
- VAT number
- BE 0435.953.632
- Registered office
- Arnaud Fraiteurlaan 15/23, 1050 Elsene
- Names & denominations
- Boehringer Ingelheim SComm
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 30 November 1988
- Peppol
- Active · Active since 30 Mar 2026
- Contact
- boehringer-ingelheim.be 02 773 33 11
- Activities · NACE
Activiteiten van hoofdkantoren
Coördinatiecentra
Groothandel in farmaceutische en medische artikelen
Overige kredietverstrekking n.e.g.